AVE plans to increase its investment in Luying Technology by 10 million yuan, with its core products being SPECT and SPECT/CT and their core components
I'm PortAI, I can summarize articles.
AVE announced plans to increase its investment in Luying Technology by 10 million yuan using its own funds. After the investment, it will hold a 9.0744% stake in Luying Technology. Luying Technology focuses on the development of domestically produced high-resolution single-photon emission computed tomography (SPECT) and its core components, providing precise, safe, economical, and convenient molecular imaging diagnostic technology solutions
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments